GenericsOrbicular–Apotex–Gland Seal the First-Market Vault with CGT Exclusivity... Orbicular–Apotex–Gland Seal the First-Market Vault with CGT Exclusivity... Read Post »
GenericsApotex Strikes First in U.S. Semaglutide Generic Push Apotex Strikes First in U.S. Semaglutide Generic Push Read Post »
GenericsZenyaku Kogyo to Take Sole Control of Rituxan Sales in Japan After Chugai E... Zenyaku Kogyo to Take Sole Control of Rituxan Sales in Japan After Chugai E... Read Post »
Generics Women & Child HealthGlenmark Expands U.S. Women’s Health Portfolio with FDA Approval of Gener... Glenmark Expands U.S. Women’s Health Portfolio with FDA Approval of Gener... Read Post »
GenericsBiocon and Zydus Receive U.S. FDA Approval for Generic Dapagliflozin Tablet... Biocon and Zydus Receive U.S. FDA Approval for Generic Dapagliflozin Tablet... Read Post »
GenericsBiocon Rolls Out Bosaya, Aukelso Denosumab Biosimilars Across U.S. Biocon Rolls Out Bosaya, Aukelso Denosumab Biosimilars Across U.S. Read Post »
GenericsNRx Preservative-Free Ketamine ANDA Advances After FDA Labeling Feedback NRx Preservative-Free Ketamine ANDA Advances After FDA Labeling Feedback Read Post »
GenericsFrom Approval to Acceptance: Teva Expands Portfolio with PONLIMSI™ and Xo... From Approval to Acceptance: Teva Expands Portfolio with PONLIMSI™ and Xo... Read Post »
GenericsNovo Nordisk Sues Dr. Reddy’s Over “Olymviq” Name, Says It Too Closel... Novo Nordisk Sues Dr. Reddy’s Over “Olymviq” Name, Says It Too Closel... Read Post »
GenericsLupin’s Pitolisant Tablets Get Tentative FDA Approval as Generic Wakix Lupin’s Pitolisant Tablets Get Tentative FDA Approval as Generic Wakix Read Post »
GenericsSandoz Launches Azelastine/Fluticasone Combination Nasal Spray in Germany a... Sandoz Launches Azelastine/Fluticasone Combination Nasal Spray in Germany a... Read Post »
Generics New Drug ApprovalViatris’ Effexor SR Becomes First Approved Treatment for Generalized Anxi... Viatris’ Effexor SR Becomes First Approved Treatment for Generalized Anxi... Read Post »
GenericsIndia’s Semaglutide Generic Boom: The Race for Market Dominance Follo... India’s Semaglutide Generic Boom: The Race for Market Dominance Follo... Read Post »
GenericsNATCO Rolls Out Affordable Generic Semaglutide for Type 2 Diabetes in India NATCO Rolls Out Affordable Generic Semaglutide for Type 2 Diabetes in India Read Post »
GenericsGlenmark Launches Milnacipran an Authorized Generic of Savella in the U.S.,... Glenmark Launches Milnacipran an Authorized Generic of Savella in the U.S.,... Read Post »
GenericsZydus Expands Semaglutide Reach in India Through Co-Marketing Deals with To... Zydus Expands Semaglutide Reach in India Through Co-Marketing Deals with To... Read Post »
